Combination Treatment for Visceral Leishmaniasis Patients Co-infected with Human Immunodeficiency Virus in India

Hdl Handle:
http://hdl.handle.net/10144/575416
Title:
Combination Treatment for Visceral Leishmaniasis Patients Co-infected with Human Immunodeficiency Virus in India
Authors:
Mahajan, Raman; Das, Pradeep; Isaakidis, Petros; Sunyoto, Temmy; Sagili, Karuna D; Lima, Marıa Angeles; Mitra, Gaurab; Kumar, Deepak; Pandey, Krishna; Van Geertruyden, Jean-Pierre; Boelaert, Marleen; Burza, Sakib
Journal:
Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America
Abstract:
There are considerable numbers of patients co-infected with Human Immunodeficiency Virus (HIV) and Visceral Leishmaniasis (VL) in the VL-endemic areas of Bihar, India. These patients are at higher risk of relapse and death, but there are still no evidence-based guidelines on how to treat them. In this study, we report on treatment outcomes of co-infected patients up to 18 months following treatment with a combination regimen.
Publisher:
Oxford University Press
Issue Date:
30-Jun-2015
URI:
http://hdl.handle.net/10144/575416
DOI:
10.1093/cid/civ530
PubMed ID:
26129756
Language:
en
ISSN:
1537-6591
Appears in Collections:
Leishmaniasis/Kala Azar

Full metadata record

DC FieldValue Language
dc.contributor.authorMahajan, Ramanen_GB
dc.contributor.authorDas, Pradeepen_GB
dc.contributor.authorIsaakidis, Petrosen_GB
dc.contributor.authorSunyoto, Temmyen_GB
dc.contributor.authorSagili, Karuna Den_GB
dc.contributor.authorLima, Marıa Angelesen_GB
dc.contributor.authorMitra, Gauraben_GB
dc.contributor.authorKumar, Deepaken_GB
dc.contributor.authorPandey, Krishnaen_GB
dc.contributor.authorVan Geertruyden, Jean-Pierreen_GB
dc.contributor.authorBoelaert, Marleenen_GB
dc.contributor.authorBurza, Sakiben_GB
dc.date.accessioned2015-08-20T19:09:39Z-
dc.date.available2015-08-20T19:09:39Z-
dc.date.issued2015-06-30-
dc.identifier.citationCombination Treatment for Visceral Leishmaniasis Patients Co-infected with Human Immunodeficiency Virus in India. 2015: Clin. Infect. Dis.en_GB
dc.identifier.issn1537-6591-
dc.identifier.pmid26129756-
dc.identifier.doi10.1093/cid/civ530-
dc.identifier.urihttp://hdl.handle.net/10144/575416-
dc.description.abstractThere are considerable numbers of patients co-infected with Human Immunodeficiency Virus (HIV) and Visceral Leishmaniasis (VL) in the VL-endemic areas of Bihar, India. These patients are at higher risk of relapse and death, but there are still no evidence-based guidelines on how to treat them. In this study, we report on treatment outcomes of co-infected patients up to 18 months following treatment with a combination regimen.en_GB
dc.languageENG-
dc.language.isoenen
dc.publisherOxford University Pressen_GB
dc.rightsArchived with thanks to Clinical Infectious Diseases' open access policy: an official publication of the Infectious Diseases Society of Americaen_GB
dc.titleCombination Treatment for Visceral Leishmaniasis Patients Co-infected with Human Immunodeficiency Virus in Indiaen
dc.identifier.journalClinical Infectious Diseases : an official publication of the Infectious Diseases Society of Americaen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.